Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment

References

• Azur, M. J., Stuart, E. A., Frangakis, C., & Leaf, P. J. (2011). Multiple imputation by chained equations: What is it and how does it work?International Journal of Methods in Psychiatric Research, 20(1), 40–49. https://doi.org/10.1002/mpr.329
   PubMed Web of Science ®Google Scholar
• Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673. https://doi.org/10.1001/jamainternmed.2014.4005
   PubMed Web of Science ®Google Scholar
• Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen, M., Chan, G., Mattick, R. P., Blyth, F., Shanahan, M., Dobbins, T., Farrell, M., & Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. The Lancet. Public Health, 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Dalton, M. S., Cluff, M. C., & Petrenas, A. M. (1994). Retention in methadone maintenance and heroin addicts’ risk of death. Addiction (Abingdon, England), 89(2), 203–209. https://doi.org/10.1111/j.1360-0443.1994.tb00879.x
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Dalton, M. S., Haldar, F., Petrenas, A. M., & Nisbet, J. G. (1996). Methadone maintenance and addicts’ risk of fatal heroin overdose. Substance Use & Misuse, 31(2), 177–196. https://doi.org/10.3109/10826089609045806
   PubMed Web of Science ®Google Scholar
• Caputi, T. L., & Sabet, K. A. (2018). Population-level analyses cannot tell us anything about individual-level marijuana-opioid substitution. American Journal of Public Health, 108(3), e12. Accessed 15 Jul 2019. https://doi.org/10.2105/AJPH.2017.304253
   PubMed Web of Science ®Google Scholar
• Cousins, G., Teljeur, C., Motterlini, N., McCowan, C., Dimitrov, B. D., & Fahey, T. (2011). Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Journal of Substance Abuse Treatment, 41(3), 252–260. https://doi.org/10.1016/j.jsat.2011.05.001
   PubMed Web of Science ®Google Scholar
• Goldschmidt, A. B., Cotton, B. P., Mackey, S., Laurent, J., Bryson, W. C., & Bond, D. S. (2018). Prevalence and correlates of loss of control eating among adults presenting for methadone maintenance treatment. Int J Behav Med, 25(6), 693–697. https://doi.org/10.1007/s12529-018-9750-z
   PubMed Web of Science ®Google Scholar
• Gossop, M., Stewart, D., Treacy, S., & Marsden, J. (2002). A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction (Abingdon, England), 97(1), 39–47. https://doi.org/10.1046/j.1360-0443.2002.00079.x
   PubMed Web of Science ®Google Scholar
• Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 374(9698), 1383–1391. https://doi.org/10.1016/S0140-6736(09)61037-0
   PubMed Web of Science ®Google Scholar
• Hall, W., West, R., Marsden, J., Humphreys, K., Neale, J., & Petry, N. (2018). It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. Addiction (Abingdon, England), 113(6), 987–988. https://doi.org/10.1111/add.14139
   PubMed Web of Science ®Google Scholar
• Hughes, M. E., Waite, L. J., Hawkley, L. C., & Cacioppo, J. T. (2004). A short scale for measuring loneliness in large surveys: Results from two population-based studies. Research on Aging, 26(6), 655–672. https://doi.org/10.1177/0164027504268574
   PubMed Web of Science ®Google Scholar
• Kroenke, K., Spitzer, R. L., Williams, J. B., & Lowe, B. (2009). An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics, 50(6), 613–621. https://doi.org/10.1176/appi.psy.50.6.613
   PubMed Web of Science ®Google Scholar
• Leece, P., Cavacuiti, C., Macdonald, E. M., Gomes, T., Kahan, M., Srivastava, A., Steele, L., Luo, J., Mamdani, M. M., & Juurlink, D. N., Canadian Drug Safety and Effectiveness Research Network (2015). Canadian Drug Safety and Effectiveness Research Network. (2015). Predictors of opioid-related death during methadone therapy. Journal of Substance Abuse Treatment, 57, 30–35. https://doi.org/10.1016/j.jsat.2015.04.008
   PubMed Web of Science ®Google Scholar
• Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797–810. https://doi.org/10.1017/S0033291713001438
   PubMed Web of Science ®Google Scholar
• Livingston, M. D., Barnett, T. E., Delcher, C., & Wagenaar, A. C. (2017). Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. American Journal of Public Health, 107(11), 1827–1829. https://doi.org/10.2105/AJPH.2017.304059
   PubMed Web of Science ®Google Scholar
• Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010). A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. Journal of Affective Disorders, 122(1-2), 86–95. https://doi.org/10.1016/j.jad.2009.06.019
   PubMed Web of Science ®Google Scholar
• Lucas, P. (2017). Rationale for cannabis-based interventions in the opioid overdose crisis. Harm Reduction Journal, 14(1), 58Retrieved from. Accessed 15 Jul 2019. https://doi.org/10.1186/s12954-017-0183-9
   PubMedGoogle Scholar
• Merlin, J. S., Long, D., Becker, W. C., Cachay, E. R., Christopolous, K. A., Claborn, K. R., Crane, H. M., Edelman, E. J., Lovejoy, T. I., Mathews, W. C., Morasco, B. J., Napravnik, S., Oʼcleirigh, C., Saag, M. S., Starrels, J. L., Gross, R., & Liebschutz, J. M. (2019). Marijuana use is not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain. J Acquir Immune Defic Syndr), 81(2), 231–237. https://doi.org/10.1097/QAI.0000000000001998
   PubMed Web of Science ®Google Scholar
• Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370(9584), 319–328. https://doi.org/10.1016/S0140-6736(07)61162-3
   PubMed Web of Science ®Google Scholar
• Mukamal, K. J., Maclure, M., Muller, J. E., & Mittleman, M. A. (2008). An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. American Heart Journal, 155(3), 465–470. https://doi.org/10.1016/j.ahj.2007.10.049
   PubMed Web of Science ®Google Scholar
• National Conference of State Legislatures (2019). Marijuana Overview. Retrieved from http://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx. Accessed 15 Jul 2019.
   Google Scholar
• Olfson, M., Wall, M. M., Liu, S. M., & Blanco, C. (2018). Cannabis use and risk of prescription opioid use disorder in the United States. American Journal of Psychiatry, 175(1), 47–53. https://doi.org/10.1176/appi.ajp.2017.17040413
   PubMed Web of Science ®Google Scholar
• Olfson, M., Wall, M. M., Wang, S., Crystal, S., & Blanco, C. (2018). Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug and Alcohol Dependence, 190, 112–119. https://doi.org/10.1016/j.drugalcdep.2018.06.004
   PubMed Web of Science ®Google Scholar
• Peng, S., Jiang, H., Du, J., Lin, S., Pan, S., Yu, S., & Zhao, M. (2018). Methadone dosage and plasma levels, SNPs of OPRM1 gene and age of first drug use were associated with outcomes of methadone maintenance Treatment. Frontiers in Genetics, 9, 450. https://doi.org/10.3389/fgene.2018.00450
   PubMed Web of Science ®Google Scholar
• Piantadosi, S., Byar, D. P., & Green, S. B. (1988). The ecological fallacy. Am J Epidemiol, 127(5), 893–904. https://doi.org/10.1093/oxfordjournals.aje.a114892
   PubMed Web of Science ®Google Scholar
• Polenick, C. A., Cotton, B. P., Bryson, W. C., & Birditt, K. S. (2019). Loneliness and illicit opioid use among methadone maintenance treatment patients. Substance Use and Misuse, 54(13), 2089–2098. https://doi.org/10.1080/10826084.2019.1628276.
   Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, M. (2016). Increases in drug and opioid overdose Deaths-United States, 2000-2014. MMWR. Morbidity and Mortality Weekly Report, 64(50-51), 1378–1382. https://doi.org/10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Scavone, J. L., Sterling, R. C., Weinstein, S. P., & Van Bockstaele, E. J. (2013). Impact of cannabis use during stabilization on methadone maintenance treatment. The American Journal on Addictions, 22(4), 344–351. https://doi.org/10.1111/j.1521-0391.2013.12044.x
   PubMed Web of Science ®Google Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths – United States, 2013-2017. CDC Morbidity and Mortality Weekly Report, 67, 1419–1427.
   Google Scholar
• Shover, C. L., Davis, C. S., Gordon, S. C., & Humphreys, K. (2019). Association of medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences, 116(26), 12624–12626. https://doi.org/10.1073/pnas.1903434116
   PubMed Web of Science ®Google Scholar
• Smith, R. A. (2020). The effects of medical marijuana dispensaries on adverse opioid outcomes. Economic Inquiry, 58(2), 569–588. https://doi.org/10.1111/ecin.12825
   Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (2018). National Survey ofSubstance Abuse Treatment Services (N-SSATS): 2017. Data on Substance Abuse Treatment Facilities. Rockville, MD. Retrieved from https://www.samhsa.gov/data/report/national-survey-substance-abuse-treatment-services-n-ssats-2017-data-substance-abuse. Accessed 15 Jul 2019.
   Google Scholar
• Tsemberis, S., Gulcur, L., & Nakae, M. (2004). Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. American Journal of Public Health, 94(4), 651–656. https://doi.org/10.2105/ajph.94.4.651
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219–2227. https://doi.org/10.1056/NEJMra1402309
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry, 73(3), 292–297. https://doi.org/10.1001/jamapsychiatry.2015.3278
   PubMed Web of Science ®Google Scholar
• Vyas, M. B., LeBaron, V. T., & Gilson, A. M. (2018). The use of cannabis in response to the opioid crisis: A review of the literature. Nursing Outlook, 66(1), 56–65. https://doi.org/10.1016/j.outlook.2017.08.012
   PubMed Web of Science ®Google Scholar
• Wang, Z. (2013). Converting odds ratio to relative risk in cohort studies with partial data information. Journal of Statistical Software, 55(5), 1–11. Retrieved from https://www.jstatsoft.org/article/view/v055i05. Accessed 15 Jul 2019. https://doi.org/10.18637/jss.v055.i05
   Web of Science ®Google Scholar
• White, W. L., Campbell, M. D., Spencer, R. D., Hoffman, H. A., Crissman, B., & DuPont, R. L. (2014). Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. Journal of Psychoactive Drugs, 46(2), 114–122. https://doi.org/10.1080/02791072.2014.901587
   PubMed Web of Science ®Google Scholar